Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: April 2022

4/30/2022 API Import to Russia (Q1 2022)

From January to March 2022, Russia imported 5,200 tons of APIs worth 53 billion RUB (customs clearance and VAT included), up 23.1% in physical terms from Q1 2021. However, the growth rate in monetary terms (rubles) is –7.5%, the first negative growth rate in 10 years.

4/29/2022 Pharmaceutical Drug Import to Russia (March and Q1 2022)

From January to March 2022, Russia imported 200.6 billion rubles’ worth of ready-made drugs (customs clearance and VAT included), up 11.5% from the same period in 2021 in monetary terms (rubles). The import of bulk drugs rose by 17.4% in rubles. In physical terms, the import of ready-made drugs was the same as one year earlier, 429.4 million packages. As for bulk drugs, the import volume was 414.5 million minimum dosage units (MDU), down 29.3% from last year.

4/28/2022 Pharmaceutical Drug Production in Russia (March and Q1 2022)

In January–March 2022, Russian manufacturers produced 190.2 billion rubles’ worth of pharmaceutical drugs (manufacturer’s prices, VAT included), up 27% from January–March 2021. In physical terms, the production volume was 1.09 billion packages, up 1.6% from the same period in 2021. If calculated in minimum dosage units (MDU), the growth rate was 2.5%, with 20 billion MDUs produced.

4/14/2022 Audit of Veterinary Drug Retail Sales on Russian Online Marketplaces in Q1 2022

From January to March 2022, the top Russian marketplaces sold RUB 338.7 million worth of veterinary drugs (retail prices, VAT included). Compared to Q1 2021, the sales increased by a factor of 2.6, with the revenue of the first three quarters exceeding that of 2020 and amounting to half of that in 2021. In physical terms, the growth rate was 72%, while the sales volume was 1.8 million minimum dosage units (MDU).